1st Quarter - Report

TERUMO BCT, INC. for TERUMO BCT, INC.

Firm
Client
Income
—
Expenses
$20,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

Global trade and tariffs

LobbyistCovered position, as disclosed
LATOYA THOMAS —

Contacted: HOUSE OF REPRESENTATIVES; Bureau of Industry and Security (BIS)

Health Issues HCR

S.735/H.R. 1796 - Reauthorization of Sickle Cell Disease and Other Heritable Blood Disorders Research, Blood and cell collection, storage, and processing Blood donation supply and quality

LobbyistCovered position, as disclosed
LATOYA THOMAS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 735 (119th), H.R. 1796 (119th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.